Janney Montgomery Scott LLC Has $1.06 Million Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Janney Montgomery Scott LLC lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 4.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 66,861 shares of the medical instruments supplier’s stock after buying an additional 2,670 shares during the period. Janney Montgomery Scott LLC’s holdings in DENTSPLY SIRONA were worth $1,062,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of DENTSPLY SIRONA by 2.8% in the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock worth $309,864,000 after buying an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of DENTSPLY SIRONA by 11.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after buying an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of DENTSPLY SIRONA by 4.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock worth $180,445,000 after buying an additional 538,531 shares during the period. AQR Capital Management LLC boosted its position in shares of DENTSPLY SIRONA by 119.4% in the first quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock worth $93,423,000 after buying an additional 3,453,662 shares during the period. Finally, Edmond DE Rothschild Holding S.A. boosted its position in shares of DENTSPLY SIRONA by 26.4% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock worth $43,526,000 after buying an additional 609,300 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $12.21 on Tuesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $11.69 and a fifty-two week high of $24.93. The stock’s 50-day moving average is $13.45 and its two-hundred day moving average is $14.57. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a market cap of $2.44 billion, a P/E ratio of -2.58, a price-to-earnings-growth ratio of 0.74 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business’s revenue was down 4.9% compared to the same quarter last year. During the same period last year, the company earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were paid a $0.16 dividend. The ex-dividend date was Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.2%. DENTSPLY SIRONA’s payout ratio is presently -13.50%.

Analyst Ratings Changes

A number of research firms recently issued reports on XRAY. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Barrington Research reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. UBS Group reduced their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Stifel Nicolaus reduced their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Finally, Wall Street Zen raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, September 26th. Two analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $18.00.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.